亚洲激情视频,久久人妻av中文字幕

5-Fluorouracil試劑返回列表頁(yè)

參考價(jià):￥350 - ￥840

具體成交價(jià)以合同協(xié)議為準(zhǔn)

型號(hào)
HY-90006
品牌
MCE
廠商性質(zhì)
代理商
所在地
杭州市

規(guī)格

10 mM * 1 mL in DMSO 500元 10000可售

200 mg 350元 10000可售

1 g 450元 10000可售

顯示更多+

在線詢價(jià) 加入對(duì)比查看聯(lián)系電話

聯(lián)系方式：鄧女士查看聯(lián)系方式

更新時(shí)間：2023-05-30 11:28:54瀏覽次數(shù)：308次

聯(lián)系我時(shí)，請(qǐng)告知來(lái)自制藥網(wǎng)

CAS號(hào)	51-21-8	產(chǎn)地	進(jìn)口
級(jí)別	其他

CAS號(hào)

51-21-8

產(chǎn)地

進(jìn)口

級(jí)別

其他

5-Fluorouracil試劑簡(jiǎn)介

5-Fluorouracil (5-FU) 是一種uracil的類似物 (nucleoside antimetabolite/analog)，是一種有效的抗腫瘤藥。5-Fluorouracil 通過(guò)抑制胸苷酸合成酶影響嘧啶的合成，從而耗盡細(xì)胞內(nèi)dTTP 池。5-Fluorouracil 誘導(dǎo)細(xì)胞凋亡 (apoptosis)，可用作化學(xué)敏化劑。5-Fluorouracil 還可抑制 HIV 病毒。5-Fluorouracil (5-FU) 可破壞外泌體特異性的 rRNA。

5-Fluorouracil試劑生物活性

5-Fluorouracil (5-FU) is an analogue of uracil and a potent antitumor agent. 5-Fluorouracil affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. 5-Fluorouracil induces apoptosis and can be used as a chemical sensitizer^[1]^[2]. 5-Fluorouracil also inhibits HIV^[3].

IC₅₀ & Target^[1]^[6]

HIV

體外研究
(In Vitro)

5-Fluorouracil (5-Fu) and NSC 123127 (Dox) show synergistic anticancer efficacy. The IC₅₀ value of 5-Fu/Dox-DNM toward human breast cancer (MDA-MB-231) cells is 0.25 μg/mL, presenting an 11.2-fold and 6.1-fold increase in cytotoxicity compared to Dox-DNM and 5-Fu-DNM, respectively^[1]. In 5-fluorouracil (5-FU) and CDDP treated NFBD1-inhibited NPC cells, the NFBD1 expression in NPC CNE1 cell lines is depleted using lentivirus-mediated short hairpin RNA, and the sensitivity of these cells is elevated. NFBD1 knockdown leads to an obvious induction of apoptosis in CDDP- or 5-FU-treated CNE1 cells^[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

體內(nèi)研究
(In Vivo)

5-Fluorouracil (23 mg/kg, 3 times/week) for 14 days, induces accelerated gastrointestinal transit associated with acute intestinal inflammation at day 3 after the start of treatment, which may have led to persistent changes in the ENS observed after days 7 and 14 of treatment contributing to delayed gastrointestinal transit and colonic dysmotility^[4].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

130.08

性狀

Solid

Formula

C₄H₃FN₂O₂

CAS 號(hào)

51-21-8

中文名稱

5-氟脲嘧啶；雙喃呋啶

運(yùn)輸條件

Room temperature in continental US; may vary elsewhere.

儲(chǔ)存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性數(shù)據(jù)

In Vitro:

DMSO : 50 mg/mL (384.38 mM; Need ultrasonic)

配制儲(chǔ)備液

濃度溶劑體積質(zhì)量	1 mg	5 mg	10 mg

1 mM	7.6876 mL	38.4379 mL	76.8758 mL
5 mM	1.5375 mL	7.6876 mL	15.3752 mL
10 mM	0.7688 mL	3.8438 mL	7.6876 mL

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液；一旦配成溶液，請(qǐng)分裝保存，避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲(chǔ)存時(shí)，請(qǐng)?jiān)?6 個(gè)月內(nèi)使用，-20°C 儲(chǔ)存時(shí)，請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨?。以下溶解方案都?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液，再依次添加助溶劑：

——為保證實(shí)驗(yàn)結(jié)果的可靠性，澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件，適當(dāng)保存；體內(nèi)實(shí)驗(yàn)的工作液，建議您現(xiàn)用現(xiàn)配，當(dāng)天使用；以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比；如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過(guò)加熱和/或超聲的方式助溶

1.

請(qǐng)依序添加每種溶劑： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
2.

請(qǐng)依序添加每種溶劑： 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
3.

請(qǐng)依序添加每種溶劑： 10% DMSO 90% corn oil
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
4.

請(qǐng)依序添加每種溶劑： 5% DMSO 40% PEG300 5% Tween-80 50% saline
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
5.

請(qǐng)依序添加每種溶劑： 5% DMSO 95% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
6.

請(qǐng)依序添加每種溶劑： 5% DMSO 95% saline
Solubility: 2.5 mg/mL (19.22 mM); Clear solution; Need ultrasonic